We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Closes Orphan Designation Loophole for Pediatric Subpopulations
FDA Closes Orphan Designation Loophole for Pediatric Subpopulations
Closing what it calls an “unintended loophole,” the FDA will no longer issue orphan drug designations for smaller pediatric subpopulations of more common diseases, unless certain criteria are met.